The purpose of this retrospective registry is to collect data about patients with acute HIT II (Heparin-induced Thrombocytopenia type II) which were treated with Lepirudin, Danaparoid, Argatroban or Fondaparinux. It is a main objective of this registry to mirror the daily routine in this indication in Germany.
Study Type
OBSERVATIONAL
Enrollment
195
Number of Participants Diagnosed With Thrombosis and/or Pulmonary Embolism After the Occurrence of HIT II
Thrombosis is a clotting in a blood vessel. Pulmonary embolism is a clot, usually from the deep veins of the legs, carried away with the venous bloodstream into the lungs, where it may block pulmonary vessels. Participants' medical records were used to abstract data that were collected on standardized hard copy Case Report Forms (CRFs).
Time frame: 19 January 2005 to 25 October 2009
Number of Participants Diagnosed With Bleeding After the Occurrence of HIT II
Participants' medical records were used to abstract data that were collected on standardized hard copy Case Report Forms (CRFs). Bleeding was documented in the participant files.
Time frame: 19 January 2005 to 25 October 2009
Number of Participants With Fatal Complications After the Occurrence of HIT II
Participants' medical records were used to abstract data that were collected on standardized hard copy Case Report Forms (CRFs). A fatal complication is defined as a complication resulting in death.
Time frame: 19 January 2005 to 25 October 2009
Number of Participants Who Underwent Amputation After the Occurrence of HIT II
Participants' medical records were used to abstract data that were collected on standardized hard copy Case Report Forms (CRFs).
Time frame: 19 January 2005 to 25 October 2009
Number of Participants Who Were Diagnosed With Thrombocytopenia (Recurrent of Persistent) After the Occurrence of HIT II
Participants' medical records were used to abstract data that were collected on standardized hard copy Case Report Forms (CRFs). Thrombocytopenia after HIT-II was documented in the participant files.
Time frame: 19 January 2005 to 25 October 2009
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
fondaparinux
Number of Participants Who Experienced Skin Changes (Erythema and Necrosis) After the Occurrence of HIT II
Participants' medical records were used to abstract data that were collected on standardized hard copy Case Report Forms (CRFs). Erythema is a redness of the skin caused by hyperemia. Necrosis is the premature death of cells or tissues.
Time frame: 19 January 2005 to 25 October 2009